(RTTNews) - Harmony Biosciences Holdings, Inc. (HRMY), a biopharmaceutical company, on Monday announced that Senior Executive Vice President and Chief Operating Officer Peter Anastasiou will become President and CEO and join the Board, effective January 1, 2027.
Mostramos publicamente o ponto principal. Crie uma conta gratuita para continuar lendo o artigo completo, salva-lo, comenta-lo e conecta-lo ao contexto de mercado e OSINT.